With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Boston Scientific is capping off a busy week with a major buyout, entering a deal worth about $14.5 billion to acquire ...

Boston will inherit products, including Penumbra’s Lightning thrombectomy systems, to advance its vascular care provision.

Boston Scientific to acquire thrombectomy firm Penumbra for $14.5bn, expanding its cardiovascular portfolio as deal reshapes ...

Inquis Medical, Inc., a privately held medical device company focused on mechanical thrombectomy for venous thromboembolic ...

Strategic investment follows a transformative year marked by the national launch of the AVENTUS thrombectomy system.

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced successful early clinical use of the ...

Surmodics, Inc. SRDX recently announced the successful early clinical use of the company’s Pounce LP (Low Profile) Thrombectomy System. With the addition of a low-profile device, the Surmodics Pounce ...

Please provide your email address to receive an email when new articles are posted on . Two new thrombectomy devices showed good safety and efficacy in the treatment of intermediate-risk pulmonary ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...